Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06216392
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-22
First Post:
2024-01-11
Brief Title:
Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis
Sponsor:
Genrix Shanghai Biopharmaceutical Co Ltd
Organization:
Genrix Shanghai Biopharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Atopic Dermatitis |
Keywords: